|
Market Closed -
Hong Kong S.E.
01:38:10 04/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 19.47 HKD | 0.00% |
|
-2.75% | -36.12% |
| 24/09 | Medtide Acquires China Land, Property for Peptide CDMO Project | MT |
| 24/09 | Medtide Inc. Announces Resignation of Li Lingmei as Executive Director, Effective September 24, 2026 | CI |
Company Valuation: Medtide Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 3,884 | 2,348 | - | - |
| Change | - | -39.54% | - | - |
| Enterprise Value (EV) 1 | 3,027 | 1,769 | 1,699 | 1,603 |
| Change | - | -41.55% | -3.96% | -5.63% |
| P/E | - | - | - | - |
| PBR | 2.31x | 1.24x | 1.08x | 0.94x |
| PEG | - | - | - | - |
| Capitalization / Revenue | 6.81x | 3.92x | 3.16x | 2.64x |
| EV / Revenue | 5.31x | 2.96x | 2.29x | 1.8x |
| EV / EBITDA | 12.6x | 7.69x | 5.43x | 4.14x |
| EV / EBIT | 14.2x | 8.59x | 6.1x | 4.71x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | - | - | - |
| Distribution rate | - | - | - | - |
| Net sales 1 | 570.1 | 598.6 | 742.3 | 890.7 |
| EBITDA 1 | 240.2 | 229.9 | 313.1 | 387.5 |
| EBIT 1 | 212.4 | 205.9 | 278.3 | 340.2 |
| Net income | - | - | - | - |
| Net Debt 1 | -857.2 | -578.9 | -649 | -744.7 |
| Reference price 2 | 27.39 | 16.56 | 16.56 | 16.56 |
| Nbr of stocks (in thousands) | 1,41,800 | 1,41,800 | - | - |
| Announcement Date | 30/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 3.65x | 9.49x | -.--% | 35Cr | |
| 16.04x | 6.01x | 11.53x | 1.86% | 6.06TCr | |
| 38x | 6.73x | 20.1x | 0.85% | 5.55TCr | |
| 29.64x | 7.94x | 26.66x | 0.05% | 5.52TCr | |
| 34.27x | 3.27x | 14.1x | -.--% | 4.33TCr | |
| 46.82x | 5.37x | 29.4x | -.--% | 4.04TCr | |
| -20.16x | 195.48x | -21.51x | -.--% | 4.16TCr | |
| 45.18x | 8.03x | 26.9x | -.--% | 3.33TCr | |
| 31.71x | 8.03x | 20.88x | 0.41% | 3.23TCr | |
| -65.46x | 12.04x | -67.36x | -.--% | 2.29TCr | |
| Average | 17.34x | 25.65x | 7.02x | 0.32% | 3.85TCr | |
| Weighted average by Cap. | 21.50x | 27.18x | 10.94x | 0.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 3880 Stock
- Valuation Medtide Inc.
Select your edition
All financial news and data tailored to specific country editions
